1. Bonar, E. E., Coughlin, L., Roche, J. S., Philyaw-Kotov, M. L., Bixler, E. A., Sinelnikov, S., & Walton, M. A. (2020). Prescription opioid misuse among adolescents and emerging adults in the United States: A scoping review. Preventive Medicine, 132, 105972. https://doi.org/10.1016/j.ypmed.2019.105972
2. Cano, M. (2021). Racial/ethnic differences in US drug overdose mortality, 2017–2018. Addictive Behaviours, 112, 106625. https://doi.org/10.1016/j.addbeh.2020.106625
3. Center for Behavioral Health Statistics and Quality. (2021). Racial/ethnic differences in substance use, substance use disorders, and substance use treatment utilization among people aged 12 or older (2015-2019). (Publication No. PEP21-07-01-001). Substance Abuse and Mental Health Services Administration. Retrieved February 2, 2023, from https://www.samhsa.gov/data/sites/default/files/reports/rpt35326/2021NSDUHSUChartbook.pdf
4. Ciccarone, D. (2021). The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Current Opinion in Psychiatry, 34(4), 344–350. https://doi.org/10.1097/YCO.0000000000000717
5. HEAL Prevention Cooperative (HPC). (2021). HPC profiles. National Institutes of Health. Retrieved January 10 2022, from, https://heal.nih.gov/files/2021-12/NIH_HEAL_Profiles_11%20%282%29%20%281%29.pdf